Impact of ErbB Receptors and Anticancer Drugs against Breast Cancer: A Review
Article in Current Pharmaceutical Biotechnology (January 2022)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us?
Article in Nanomedicine (July 2021)
Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells
Article in Cell Death & Disease (April 2021)